Village Farms Posts 27% Revenue Growth on Record International Cannabis Exports — Village Farms International, Inc.

Event summary

Q1 2026 revenue rose 27% to $50.2M, with net income of $2.9M ($0.03 per share).
International export sales surged 171% YoY, driven by EU-GMP certified products.
Adjusted EBITDA from continuing operations increased 118% to $9.9M (20% of sales).
Company completed facility upgrades, now operating the world’s largest EU-GMP certified cannabis facility.
Share repurchases totaled $6.4M, with $9.2M in capital expenditures and $15M in income taxes paid.

The big picture

Village Farms' Q1 2026 results highlight its strategic pivot toward a unified cannabis operating model, with a focus on international expansion and regulatory compliance. The company's record international export sales and facility upgrades position it as a leader in the global cannabis market. The broader industry context includes increasing demand for medical cannabis, particularly in Germany, and the potential for U.S. regulatory changes to support market growth.

What we're watching

Regulatory Tailwinds: The impact of President Trump's executive order rescheduling marijuana to Schedule III on Village Farms' U.S. operations and strategic M&A opportunities.
Execution Risk: The pace at which the company's capacity expansion projects in Canada and the Netherlands contribute to stronger sales growth.
Profitability Dynamics: Whether Village Farms can sustain its adjusted EBITDA growth rate of 118% YoY amid increasing global demand and competitive pressures.